Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Brent Arakaki
Aetion, Inc.
Poster(s):
(102) Evaluation of postmenopausal hemorrhage following Moderna COVID-19 vaccines: results from surveillance data analysis and interim results from a US claims database cohort study
Monday, August 26, 2024
8:00 AM – 6:00 PM
CEST
(129) Safety of Moderna’s mRNA-1273.222 bivalent omicron-containing vaccine: interim results from a US claims database cohort study
Monday, August 26, 2024
8:00 AM – 6:00 PM
CEST
